Literature DB >> 1451050

Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study.

I Shima1, Y Sasaguri, J Kusukawa, H Yamana, H Fujita, T Kakegawa, M Morimatsu.   

Abstract

BACKGROUND: Matrix metalloproteinases (MMP) are a gene family of zinc enzymes capable of degrading almost all of the extracellular matrix macromolecules in vivo. Their enzymic activities are believed to be responsible for tumor invasion and metastasis.
METHODS: In this study, using peroxidase-antiperoxidase method, monospecific antisera against MMP-1 (tissue collagenase), MMP-2 (type IV collagenase/72-kilodalton [KD] gelatinase), and MMP-3 (stromelysin) were applied to 29 squamous cell carcinomas and normal epithelium of the esophagus to identify cells synthesizing and secreting these enzymes.
RESULTS: Immunoreactivity of MMP-1, -2, and -3 was observed in small cancer nests of the deeply invasive or marginal portion of the tumor. Among the 29 patients studied, the presence of at least one MMP was observed in 17 (58.6%). All three enzymes were observed in six (20.6%) patients, MMP-2 and -3 in five (17.2%) patients, only MMP-2 in three (10.3%) patients, and MMP-3 alone in three (10.3%) patients. There was a good correlation among histologic stage and tumor invasion, lymph node metastasis, and MMP expression. In particular, expression of MMP-2 and -3 was closely related to lymph node metastasis and vascular invasion.
CONCLUSIONS: These results suggest that MMP, especially MMP-2 and -3, play an important role in tumor invasion and metastasis and that analysis of MMP-2 and -3 production is useful for evaluation of malignant potential in esophageal carcinoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1451050     DOI: 10.1002/1097-0142(19921215)70:12<2747::aid-cncr2820701204>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  34 in total

1.  Expression of matrix metalloproteinases in invasive pulmonary adenocarcinoma with bronchioloalveolar component and atypical adenomatous hyperplasia.

Authors:  F Kumaki; K Matsui; T Kawai; Y Ozeki; Z X Yu; V J Ferrans; W D Travis
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

2.  Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis.

Authors:  Laszlo Herszenyi; Istvan Hritz; Istvan Pregun; Ferenc Sipos; Mark Juhasz; Bela Molnar; Zsolt Tulassay
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

3.  Expression of metalloproteinases endometrial stromal sarcoma: immunohistochemical study using image analysis.

Authors:  P Liokumovich; I Goldberg; B Davidson; W H Gotlieb; T Zahavi; G Ben-Baruch; I Reder; J Kopolovic
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

4.  Oxymatrine induces apoptosis and inhibits invasion in Gallbladder carcinoma via PTEN/PI3K/AKT pathway.

Authors:  Liqiang Qian; Xiaqin Li; Penghui Ye; Gang Wang; Wei Dai; Yan Liu; Quangen Gao; Genhai Shen
Journal:  Cytotechnology       Date:  2017-11-23       Impact factor: 2.058

5.  Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer.

Authors:  T Ikebe; M Shinohara; H Takeuchi; M Beppu; S Kurahara; S Nakamura; K Shirasuna
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

6.  May High MMP-2 and TIMP-2 Expressions Increase or Decrease the Aggressivity of Oral Cancer?

Authors:  Bijayatha Shrestha; Dipshikha Bajracharya; Aditi Amit Byatnal; Asha Kamath; Raghu Radhakrishnan
Journal:  Pathol Oncol Res       Date:  2016-11-16       Impact factor: 3.201

7.  Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma.

Authors:  Sumana Mukherjee; Mark J Roth; Sanford M Dawsey; Wusheng Yan; Jaime Rodriguez-Canales; Heidi S Erickson; Nan Hu; Alisa M Goldstein; Philip R Taylor; Annely M Richardson; Michael A Tangrea; Rodrigo F Chuaqui; Michael R Emmert-Buck
Journal:  J Transl Med       Date:  2010-10-05       Impact factor: 5.531

8.  Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.

Authors:  S Samantaray; R Sharma; T K Chattopadhyaya; S Datta Gupta; R Ralhan
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-16       Impact factor: 4.553

9.  Esophageal squamous cell carcinoma: pathology and prognosis.

Authors:  H Ide; T Nakamura; K Hayashi; T Endo; A Kobayashi; R Eguchi; F Hanyu
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

10.  Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer.

Authors:  Ayla Acar; Anil Onan; Ugur Coskun; Aytug Uner; Umit Bagriacik; Funda Atalay; Diclehan Kilic Unsal; Haldun Guner
Journal:  Med Oncol       Date:  2007-12-11       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.